Galera Therapeutics Inc

8-K Unregistered sale of equity; Regulation FD disclosure Jul 31, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jul 13, 2026 8-K Other events Jul 7, 2026 8-K Other events May 19, 2026 8-K Amended charter or bylaws May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Shareholder vote results May 11, 2026 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Regulation FD disclosure Apr 14, 2026 8-K Other events Apr 9, 2026 8-K Other events Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Amended charter or bylaws Feb 18, 2026 8-K Director or officer change Feb 12, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement Oct 27, 2025 8-K Entered a material agreement Oct 21, 2025 8-K Entered a material agreement Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K/A Mar 24, 2025 8-K Shareholder vote results Feb 25, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Dec 31, 2024 8-K Other events Dec 20, 2024 10-Q Quarter ended 2024-09-30 Dec 13, 2024 8-K Shareholder vote results Oct 18, 2024 8-K Delisting notice or listing-rule failure Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release); Director or officer change; Other events Aug 14, 2024 8-K Regulation FD disclosure Aug 8, 2024 8-K Director or officer change Jun 7, 2024 8-K Delisting notice or listing-rule failure Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 3, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Delisting notice or listing-rule failure Mar 27, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023